Q: Good morning.
I would be interested in your thoughts about CTLT which was last addressed in Q&A in Dec 2019. It seems to be in a sweet space of the logistics and delivery of COVID-19 vaccines; it has contracts with JNJ and AZN; and Argus has a $100 price target on it. Worthwhile to purchase as a compliment to the big pharma companies themselves or are there better options in the same space?
As others have said, thank you for the amazing work 5i does!
Dave
I would be interested in your thoughts about CTLT which was last addressed in Q&A in Dec 2019. It seems to be in a sweet space of the logistics and delivery of COVID-19 vaccines; it has contracts with JNJ and AZN; and Argus has a $100 price target on it. Worthwhile to purchase as a compliment to the big pharma companies themselves or are there better options in the same space?
As others have said, thank you for the amazing work 5i does!
Dave
Q: Realizing [again] that this is an American listed co., can you provide an opinion on suitability for holding in a US$ RRIF? Is it a good company in your opinion?